Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

A Viral Fix for Diabetes

MP3 WAV

  • Can one injection of an engineered virus carrying a gene cure Type Two diabetes? That's what a new study accomplished in mice which doesn't mean much to humans yet, but certainly stokes excitement considering type two diabetes has become an epidemic.

    The engineered virus, called an AAV, carried a gene called a fibroblast growth factor twenty one or FGF-twenty one. Once injected, the virus was able to alter cells in the liver, fat, and skeletal muscles and enable them to keep producing FGF twenty one.

    The reason FGF twenty one is important is this small protein is normally secreted by several organs in our bodies. It regulates our metabolism, how sugar is used, and how sensitive our bodies are to insulin. But diabetics don't produce enough of it.

    This growth factor works by binding to receptors on the surface of cells. Prior studies have already shown that giving it to obese or diabetic rats, mice and monkeys made them lose weight, lowered their blood glucose and insulin resistance.

    However, FGF twenty one does not make a good drug since it has a very short lifespan in the body due to its degradation by enzymes and elimination by the kidney. But this study gets around that problem because by introducing it into various cells and organs using an engineered virus, the growth factor is being produced continuously.

    It worked on two mouse strains so far. The next step is to test the approach on larger animals and then onto clinical trials with humans. It's among a handful of promising therapies being developed for diabetes. One day, we may just have a cure.

More Information

Gene therapy shown to cure type 2 diabetes and obesity in mice, researchers report
A single administration of a therapeutic vector in mouse models cures type 2 diabetes and obesity in the absence of long-term side effects, researchers report. In healthy mice, the therapy prevents age-associated weight gain and insulin resistance and promotes healthy aging...

FGF21 gene therapy as treatment for obesity and insulin resistance
This study describes the use of adeno-associated viral (AAV) vectors to achieve long-term production of fibroblast growth factor 21 (FGF21) to treat obesity and insulin resistance. AAV-FGF21 gene transfer to healthy animals also prevented age-associated weight gain and insulin resistance...

MedlinePlus: Hormones
Hormones are your body's chemical messengers. They travel in your bloodstream to tissues or organs. They work slowly, over time, and affect many different processes, including growth and development, metabolism (how your body gets energy from the foods you eat), sexual function, reproduction, and mood...

Two individuals wearing headphones stand in a recording booth, speaking into microphones with a music stand holding printed pages between them.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.